| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.09 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.09 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.054 | 0.09 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | 0.19 | 0.09 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.09 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.09 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.063 | 0.09 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.058 | 0.09 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.09 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.09 |